Disponibilidad y precios de medicamentos esenciales genéricos en farmacias y boticas del sector público y privado – 2025

Abstract

La presente investigación tuvo como objetivo determinar la disponibilidad y precios de medicamentos esenciales genéricos en farmacias y boticas del sector publico y privado_2025. Es una investigación aplicada, con enfoque cuantitativo, diseño no experimental, alcance descriptivo-comparativo y corte transversal. estuvo conformada por 16 oficinas farmacéuticas (1 del sector público y 15 del sector privado) y 60 trabajadores de ambos sectores. Se evaluó a 32 medicamentos del (PNUME), donde La disponibilidad de los medicamentos esenciales genéricos fue predominantemente regular. La principal limitación reportada fue la supervisión y control por la DIGEMID. Asimismo, se evidenciaron diferencias marcadas en los precios entre ambos sectores.
The objective of this research was to determine the availability and prices of essential generic medicines in public and private sector pharmacies and drugstores in 2025. This is an applied study with a quantitative approach, a non-experimental design, a descriptive-comparative scope, and a cross-sectional nature. The study included 16 pharmaceutical establishments (1 from the public sector and 15 from the private sector) and 60 employees from both sectors. A total of 32 medicines from the National List of Essential Medicines (PNUME) were evaluated; the availability of these essential generic medicines was found to be, for the most part, fair (moderate). The primary limitation reported concerned the supervision and control provided by DIGEMID. Furthermore, marked differences in prices were observed between the two sectors.

Description

Citation

Vancouver

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2